105 related articles for article (PubMed ID: 16208818)
1. HIV/AIDS research after HAART.
Gallo RC
Res Initiat Treat Action; 2005; 11(1):39-41. PubMed ID: 16208818
[No Abstract] [Full Text] [Related]
2. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
[TBL] [Abstract][Full Text] [Related]
3. Grim news for vaccine.
AIDS Patient Care STDS; 2002 Oct; 16(10):513-4. PubMed ID: 12442739
[No Abstract] [Full Text] [Related]
4. The QUEST trial, a paradigm of HIV collaborative research.
Goh LE; McDade H; Kinloch S; Perrin L; Cooper D; Phillips A; Hoen B; Autran B; Sonnerborg A; Tsoukas C
Nat Med; 2000 Nov; 6(11):1194. PubMed ID: 11062508
[No Abstract] [Full Text] [Related]
5. Biomedical methods for HIV prevention: new setbacks.
Laurence J
AIDS Read; 2008 Apr; 18(4):163-4. PubMed ID: 18472438
[No Abstract] [Full Text] [Related]
6. A novel approach to HIV therapy: highly active antiretroviral therapy and autologous hematopoietic cell transplantation.
Pippi F
Med Hypotheses; 2008; 70(2):291-3. PubMed ID: 17681707
[TBL] [Abstract][Full Text] [Related]
7. [HIV infection: emerging issues and new challenges].
Calza L; Manfredi R; Chiodo F
Recenti Prog Med; 2006 Dec; 97(12):771-80. PubMed ID: 17252736
[TBL] [Abstract][Full Text] [Related]
8. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
[TBL] [Abstract][Full Text] [Related]
9. 30 years after HIV identification: where to from here?
Stover J
Expert Rev Anti Infect Ther; 2011 Nov; 9(11):947-9. PubMed ID: 22029511
[No Abstract] [Full Text] [Related]
10. Failure to eradicate HIV despite fully successful HAART initiated in the first days of life.
Viganò A; Trabattoni D; Schneider L; Ottaviani F; Aliffi A; Longhi E; Rusconi S; Clerici M
J Pediatr; 2006 Mar; 148(3):389-91. PubMed ID: 16615974
[TBL] [Abstract][Full Text] [Related]
11. Does residual virus replication during successful HAART lead to HIV-1 genetic evolution?
Aquaro S; Svicher V; Perno CF
J HIV Ther; 2006 Dec; 11(4):84-8. PubMed ID: 17578212
[No Abstract] [Full Text] [Related]
12. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
[TBL] [Abstract][Full Text] [Related]
13. How does HIV impact on non-AIDS events in the era of HAART?
Barber TJ; Hughes A; Dinsmore WW; Phillips A
Int J STD AIDS; 2009 Jan; 20(1):1-3. PubMed ID: 19103883
[TBL] [Abstract][Full Text] [Related]
14. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act.
Burgoyne RW; Tan DH
J Antimicrob Chemother; 2008 Mar; 61(3):469-73. PubMed ID: 18174196
[TBL] [Abstract][Full Text] [Related]
15. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
[TBL] [Abstract][Full Text] [Related]
16. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
[TBL] [Abstract][Full Text] [Related]
17. Control of HIV/AIDS and AIDS-related conditions in Africa with special reference to periodontal diseases.
Reddy J
J Int Acad Periodontol; 2007 Jan; 9(1):2-12. PubMed ID: 17274234
[TBL] [Abstract][Full Text] [Related]
18. [HIV infection--current challenges].
Salzberger B; Fätkenheuer G; Diehl V
Internist (Berl); 2003 Jun; 44(6):675-7. PubMed ID: 14567103
[No Abstract] [Full Text] [Related]
19. Immune reconstitution inflammatory syndrome among HIV/AIDS patients during highly active antiretroviral therapy in Addis Ababa, Ethiopia.
Huruy K; Mulu A; Mengistu G; Shewa-Amare A; Akalu A; Kassu A; Andargie G; Elias D; Torben W
Jpn J Infect Dis; 2008 May; 61(3):205-9. PubMed ID: 18503170
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy.
Tanzi E; Esposito S; Bojanin J; Amendola A; Trabattoni D; Pariani E; Pinzani R; Zanetti A; Principi N
J Med Virol; 2006 Apr; 78(4):440-5. PubMed ID: 16482542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
